RGRoseane Lopes da Silva Grecco

Roseane Lopes da Silva Grecco

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roseane Lopes da Silva Grecco has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    CONTRIBUIÇÃO DE VARIANTES GENÉTICAS NO GENE DO RECEPTOR DE MORTE CELULAR PROGRAMADA 1 (PD-1) PARA O DESENVOLVIMENTO DA PRÉ-ECLÂMPSIA

    by Sarah Cristina Sato Vaz Tanaka, Roseane Lopes da Silva Grecco, Andrezza Cristina Cancian Hortolani Cunha, Naila Francis Paulo de Oliveira, Fernanda Bernadelli de Vito, Marly Spadotto Balarin, Cristina Wide Pissetti

    A pré-eclâmpsia (PE), condição hipertensiva exclusiva da gestação, é uma desordem multissistêmica de etiologia desconhecida. Sugere-se que a pré-eclâmpsia se desenvolva quando o processo inflamatório, comum a todas as mulheres na segunda metade da gestação, torna-se descompensado (teoria inflamatória). A desordem seria, portanto, o resultado da resposta inflamatória sistêmica contra a gestação. Morte celular programada-1 (PD-1) e seu ligante (PD-L1) têm surgido como moléculas importantes na regulação da tolerância imunológica. Sabendo-se que a pré-eclâmpsia está associada a má adaptação da tolerância imunológica, é interessante estudar variantes genéticas existentes no gene PD-1 e que podem estar associadas com maior predisposição à doença. Portanto, o objetivo deste estudo é identificar a frequência dos polimorfismos genéticos rs 2227982 e rs 36084323 no gene PD-1 em mulheres com pré-eclâmpsia e mulheres do grupo controle, buscando associá-los com a predisposição ao desenvolvimento da PE. A amostra foi composta por 89 gestantes com pré-eclâmpsia e 174 mulheres sem histórico de alterações pressóricas durante a gestação. A obtenção dos genótipos foi obtida por discriminação alélica, usando a metodologia TaqMan. As análises estatísticas foram realizadas de acordo com o tipo de variável, no programa IBM SPSS. Houve associação entre os genótipos AA e GA do polimorfismo rs2227982 e o grupo controle. Não houve associação entre o polimorfismo rs36084323 e a PE. Nossos achados apontam para a necessidade de mais estudos de polimorfismos genéticos da via PD-1/PD-1L em mulheres com PE.

  • Open Access

    Relation of TGF-β1 gene with the prognosis of patients with Covid-19

    by Christiane Ruffato Carminati, Anna Cecília Dias Maciel Carneiro, Andrezza Cristina Cancian Hortolani da Cunha, Loren Queli Pereira, Fernanda Bernadelli De Vito, Marcos Vinicíus da Silva, Virmondes Rodrigues Júnior, Mariângela Torreglosa Ruiz Cintra, Roseane Lopes da Silva Grecco, Sarah Cristina Sato Vaz Tanaka, et al.

    This study aimed to investigate the role of the TGF-β1 gene in SARS-CoV-2 infection. A total of 178 individuals diagnosed with Covid-19 participated and, they were divided in two groups related to the outcome (discharge or death). Genotyping of rs1800468 and rs1800469 polymorphisms of TGF-β1 gene was performed in 178 samples, using the allelic discrimination technique and, gene expression analysis was performed in 93 samples by Real Time PCR. There was no association between the genotypic frequencies of TGF-β1 gene polymorphisms analyzed with the prognosis of patients with Covid-19. There was no significant difference between gene expression and the clinical data evaluated. A statistically significant difference was observed in the expression of the TGF-β1 gene between the CT and TT genotypes of the rs1800469 polymorphism, with lower gene expression in the presence of the TT genotype. Regarding the rs1800468 polymorphism, no statistically significant difference was observed in the expression of the TGF-β1 gene in relation to the analyzed genotypes. The present study concluded that the rs1800468 and rs1800469 polymorphisms of the TGF-β1 gene are not associated with the prognosis of patients with Covid-19 and which the TT genotype of the rs1800469 polymorphism reduces the expression of TGF-β1.

  • Open Access

    Contribution of rs1799998 polymorphism in CYP11B2 gene in susceptibility to preeclampsia

    by Kaio Raffael Valotta Bezerra, Sarah Cristina Sato Vaz Tanaka, Vanessa Resende Souza Silva, Marina Carvalho Paschoinni, Roseane Lopes da Silva Grecco, Fernanda Caroline Soardi, Marly Aparecida Spadotto Balarin

    Objectives: the present study aimed to evaluate the association between the rs1799998 polymorphism of the CYP11B2 gene and the susceptibility to preeclampsia (PE) in a Brazilian population. Methods: the study group comprised 61 women who were diagnosed with PE. The control group included 116 women who did not show changes in their blood pressure levels during their pregnancies. The rs1799998 polymorphism of the CYP11B2 gene was amplified by allele-specific polymerase chain reaction (PCR). A multiple logistic regression analysis was performed using the SNPStat program to evaluate the risk of the CYP11B2 gene rs1799998 polymorphism contributing to PE. Results: the PE group had the following genotypes: 1.64% CC, 91.80% CT, and 6.56% TT. In the control group, the observed genotypic frequencies were: 11% CC, 73% CT, and 16% TT. The genotypic frequency distribution did not fit the Hardy Weinberg Equilibrium (HWE) in either study group. The multiple logistic regression analysis showed a statistically significant difference for the rs1799998 polymorphism in the recessive model. Conclusion: the results suggest an association between the recessive model of C/C genotype of the rs1799998 polymorphism of the CYP11B2 gene and susceptibility to PE.


  • Open Access

    Can the genetic polymorphisms of the folate metabolism have an influence in the polycystic ovary syndrome?

    by Tayssia Beatriz dos Santos, Helena Korres de Paula, Marly Aparecida Spadotto Balarin, Roseane Lopes Silva-Grecco, Marco Fábio Prata Lima, Elisabete Aparecida Mantovani Rodrigues de Resende, Mariana Kefalas Oliveira Gomes, Mariangela Torreglosa Ruiz Cintra

    Key words: Polycystic ovary syndrome; folic acid; polymorphism


  • Open Access

    Maternally inherited partial monosomy 9p (pter → p24.1) and partial trisomy 20p (pter → p12.1) characterized by microarray comparative genomic hybridization

    by Érika L. Freitas, Susan M. Gribble, Milena Simioni, Társis P. Vieira, Roseane L. Silva‐Grecco, Marly A. S. Balarin, Elena Prigmore, Ana C. Krepischi‐Santos, Carla Rosenberg, Karoly Szuhai, et al.

    We report on a 17‐year‐old patient with midline defects, ocular hypertelorism, neuropsychomotor development delay, neonatal macrosomy, and dental anomalies. DNA copy number investigations using a Whole Genome TilePath array consisting, of 30K BAC/PAC clones showed a 6.36 Mb deletion in the 9p24.1–p24.3 region and a 14.83 Mb duplication in the 20p12.1–p13 region, which derived from a maternal balanced t(9;20)(p24.1;p12.1) as shown by FISH studies. Monosomy 9p is a well‐delineated chromosomal syndrome with characteristic clinical features, while chromosome 20p duplication is a rare genetic condition. Only a handful of cases of monosomy 9/trisomy 20 have been previously described. In this report, we compare the phenotype of our patient with those already reported in the literature, and discuss the role of DMRT, DOCK8, FOXD4, VLDLR, RSPO4, AVP, RASSF2, PROKR2, BMP2, MKKS, and JAG1, all genes mapping to the deleted and duplicated regions.